Enara Bio ^Companies

Enara Bio is a science-led organization that focuses on developing targeted cancer immunotherapies. Their main goal is to exploit previously uncharted genomic dark matter to develop cancer immunotherapies that provide lasting benefits for a broad range of patients. They have built an innovative technology platform called EDAPT®, which integrates bioinformatics, immunopeptidomics, target validation, and immunology. This platform enables them to discover a novel class of cancer-specific targets called Dark Antigens. With a diverse and experienced team, Enara Bio is dedicated to advancing the field of immuno-oncology and developing novel therapeutics for the benefit of cancer patients and their families.